Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Danny Did Foundation is a non-profit organization dedicated to preventing deaths caused by seizures and advancing awareness of Sudden Unexpected Death in Epilepsy (SUDEP). Founded in 2010 by Mike and Mariann Stanton following the death of their son Danny, the foundation works to improve communication between medical professionals and families regarding SUDEP risks. A core component of its mission is the mainstreaming of seizure detection and prediction devices, which the foundation views as essential safety tools. Through its grant program, Danny Did provides financial assistance to families for the purchase of these life-saving technologies. The organization also collaborates with researchers, medical technology companies, and other epilepsy advocacy groups to enhance patient safety and clinical care. By providing resources and education, the foundation aims to empower the epilepsy community and reduce the incidence of seizure-related mortality.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Danny Did Foundation.